基于BTLA及调节T细胞探讨294例风湿病患者血小板病变机制(3)
第1页 |
参见附件。
[9]姚茹冰,胡兵,郭郡浩,等.类风湿性关节炎血小板参数变化与病情活动相关性的研究[J].中国微循环,2005,9(2):117-118.
[10]李永平,刘长云,周建光,等.幽门螺杆菌感染对血小板参数的影响[J].海军医学杂志,2007,28(2):119-120.
[11]陆小婵,卢冬,潘云.血小板参数在急性白血病疗效观察中的应用[J],国际检验医学杂志,2006,27(10):870-871.
[12]王俊祥,顾光,陈海英,等.血小板参数与强直性脊柱炎病情活动的相关性研究[J].河北医药,2008,30(4):472-473.
[13]邱群芳,罗裕旋,魏建伟.糖皮质激素对类风湿关节炎患者血清中B、T淋巴细胞弱化因子表达的影
响[J].国际检验医学杂志,2011,32(6):625-627.
[14]Wan Lei,Liu Jian.Changes of CD4+ CD25+ Regulatory T Cells,Foxp3+ in Adjuvant Arthritis Rats with Damage of Pulmonary Function and Effects of Tripterygium Glycosides Tablet[J].International Journal of Rheumatology,2012:348450.
[15]Morbach H,Girschick HJ.B-cell targeted therapy for children and adolescents with rheumatic diseases[J].Rheumatol,2013,72(4):347-353.
[16]Wakamatsu E,Mathis D,Benoist C.Convergent and divergent effects of costimulatory molecules in conventional and regulatory CD4+ T cells[J].Proc Natl Acad Sci USA,2013,110(3):1023-1028.
[17]Pasero C,Olive D.Interfering with coinhibitory molecules: BTLA/HVEM as new targets to enhance anti-tumor immunity[J].Immunol Lett,2013,151(1-2):71-75.
您现在查看是摘要介绍页,详见PDF附件。